{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:56:42Z","timestamp":1785607002862,"version":"3.56.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00702-025-03073-0","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T06:56:07Z","timestamp":1766386567000},"page":"1039-1052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is there a link between multiple sclerosis and Alzheimer disease? A critical note"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"3073_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/brain\/awn119","volume":"131","author":"JM Anderson","year":"2008","unstructured":"Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, Franklin RJ, Giovannoni G, Compston DA, Baker D, Spillantini MG, Chandran S (2008) Abnormally phosphorylated Tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain 131:1736\u20131748","journal-title":"Brain"},{"key":"3073_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JAD-200755","volume":"78","author":"BM Asken","year":"2020","unstructured":"Asken BM, Elahi FM, La Joie R, Strom A, Staffaroni AM, Lindbergh CA, Apple AC, You M, Weiner-Light S, Brathaban N, Fernandes N, Karydas A, Wang P, Rojas JC, Boxer AL, Miller BL, Rabinovici GD, Kramer JH, Casaletto KB (2020) Plasma glial fibrillary acidic protein levels differ along the spectra of amyloid burden and clinical disease stage. J Alzheimers Dis 78:265\u2013276","journal-title":"J Alzheimers Dis"},{"key":"3073_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.msard.2018.04.004","volume":"22","author":"JR Avasarala","year":"2018","unstructured":"Avasarala JR, Jones JR, Rogers CR (2018) Forkhead box C1 gene variant causing glaucoma and small vessel angiopathy can mimic multiple sclerosis. Mult Scler Relat Disord 22:157\u2013160","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-022-01823-1","volume":"28","author":"A Bar-Or","year":"2022","unstructured":"Bar-Or A, Banwell B, Berger JR, Lieberman PM (2022) Guilty by association: Epstein-Barr virus in multiple sclerosis. Nat Med 28:904\u2013906","journal-title":"Nat Med"},{"key":"3073_CR5","doi-asserted-by":"publisher","first-page":"e0231720","DOI":"10.1371\/journal.pone.0231720","volume":"15","author":"TG Beach","year":"2020","unstructured":"Beach TG, Adler CH, Zhang N, Serrano GE, Sue LI, Driver-Dunckley E, Mehta SH, Zamrini EE, Sabbagh MN, Shill HA, Belden CM, Shprecher DR, Caselli RJ, Reiman EM, Davis KJ, Long KE, Nicholson LR, Intorcia AJ, Glass MJ, Walker JE, Callan MM, Oliver JC, Arce R, Gerkin RC (2020) Severe hyposmia distinguishes neuropathologically confirmed dementia with lewy bodies from alzheimer\u2019s disease dementia. PLoS ONE 15:e0231720","journal-title":"PLoS ONE"},{"key":"3073_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1055\/s-2006-956758","volume":"27","author":"RH Benedict","year":"2007","unstructured":"Benedict RH, Bobholz JH (2007) Multiple sclerosis. Semin Neurol 27:78\u201385","journal-title":"Semin Neurol"},{"key":"3073_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict RHB, Amato MP, DeLuca J, Geurts JJG (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19:860\u2013871","journal-title":"Lancet Neurol"},{"key":"3073_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000490349","volume":"65","author":"H Benveniste","year":"2019","unstructured":"Benveniste H, Liu X, Koundal S, Sanggaard S, Lee H, Wardlaw J (2019) The glymphatic system and waste clearance with brain aging: a review. Gerontology 65:106\u2013119","journal-title":"Gerontology"},{"key":"3073_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamaneurol.2025.2972","volume":"82","author":"SNM Binks","year":"2025","unstructured":"Binks SNM, Graff-Radford J (2025) Evolving role of plasma phosphorylated Tau 217 in alzheimer disease\u2014time for Tau. JAMA Neurol 82:981\u2013982","journal-title":"JAMA Neurol"},{"key":"3073_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375:296\u2013301","journal-title":"Science"},{"key":"3073_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in alzheimer disease. Nat Rev Neurol 6:131\u2013144","journal-title":"Nat Rev Neurol"},{"key":"3073_CR12","doi-asserted-by":"publisher","first-page":"102349","DOI":"10.1016\/j.msard.2020.102349","volume":"45","author":"S Borrelli","year":"2020","unstructured":"Borrelli S, Genoud-Prachex T, Meyer M, D\u00e9monet JF, Rouaud O (2020) Unsuspected alzheimer disease in a patient with multiple sclerosis and progressive aphasia. Mult Scler Relat Disord 45:102349","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR13","doi-asserted-by":"publisher","first-page":"1204852","DOI":"10.3389\/fnagi.2023.1204852","volume":"15","author":"MS Boukhvalova","year":"2023","unstructured":"Boukhvalova MS, Kastrukoff L, Blanco JCG (2023) Alzheimer\u2019s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT). Front Aging Neurosci 15:1204852","journal-title":"Front Aging Neurosci"},{"key":"3073_CR14","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s10072-019-03875-7","volume":"40","author":"M Branco","year":"2019","unstructured":"Branco M, Ruano L, Portaccio E, Goretti B, Niccolai C, Patti F, Chisari C, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Bellomi F, Simone M, Viterbo RG, Amato MP (2019) Aging with multiple sclerosis: prevalence and profile of cognitive impairment. Neurol Sci 40:1651\u20131657","journal-title":"Neurol Sci"},{"key":"3073_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/ana.27027","volume":"96","author":"MR Brier","year":"2024","unstructured":"Brier MR, Schindler SE, Salter A, Perantie D, Shelley N, Judge B, Keefe S, Kirmess KM, Verghese PB, Yarasheski KE, Venkatesh V, Raji CA, Gordon BA, Bateman RJ, Morris JC, Naismith RT, Holtzman DM, Benzinger TLS, Cross AH (2024) Unexpected low rate of amyloid-beta pathology in multiple sclerosis patients. Ann Neurol 96:453\u2013459","journal-title":"Ann Neurol"},{"key":"3073_CR16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.4103\/NRR.NRR-D-24-01459","volume":"21","author":"NAH Brooks","year":"2026","unstructured":"Brooks NAH, Riar I, Klegeris A (2026) Mitochondrial damage-associated molecular patterns: neuroimmunomodulators in central nervous system pathophysiology. Neural Regen Res 21:1322\u20131338","journal-title":"Neural Regen Res"},{"key":"3073_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1385\/MN:27:3:325","volume":"27","author":"GC Brown","year":"2003","unstructured":"Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27:325\u2013355","journal-title":"Mol Neurobiol"},{"key":"3073_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1352458518814113","volume":"26","author":"G Bsteh","year":"2020","unstructured":"Bsteh G, Berek K, Hegen H, Teuchner B, Auer M, Wurth S, Di Pauli F, Deisenhammer F, Berger T (2020) Smelling multiple sclerosis: different qualities of olfactory function reflect either inflammatory activity or neurodegeneration. Mult Scler 26:57\u201368","journal-title":"Mult Scler"},{"key":"3073_CR19","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1093\/brain\/awab454","volume":"145","author":"A Carotenuto","year":"2022","unstructured":"Carotenuto A, Cacciaguerra L, Pagani E, Preziosa P, Filippi M, Rocca MA (2022) Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability. Brain 145:2785\u20132795","journal-title":"Brain"},{"key":"3073_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/JAD-201140","volume":"80","author":"F Chen","year":"2021","unstructured":"Chen F, Zhang Y, Wang L, Wang T, Han Z, Zhang H, Gao S, Hu Y, Liu G (2021) PLCG2 rs72824905 variant reduces the risk of alzheimer\u2019s disease and multiple sclerosis. J Alzheimers Dis 80:71\u201377","journal-title":"J Alzheimers Dis"},{"key":"3073_CR21","doi-asserted-by":"crossref","unstructured":"Chiang HS, Khera A, Stopschinski BE, Stuve O, Hart J Jr., Kelley B, Nguyen T (2022) Cognitive decline in older people with multiple sclerosis-a narrative review of the literature. Geriatr (Basel) 7:61","DOI":"10.3390\/geriatrics7030061"},{"key":"3073_CR22","doi-asserted-by":"publisher","first-page":"1214652","DOI":"10.3389\/fnins.2023.1214652","volume":"17","author":"EB Cho","year":"2023","unstructured":"Cho EB, Jung SY, Jung JH, Yeo Y, Kim HJ, Han K, Shin DW, Min JH (2023) The risk of dementia in multiple sclerosis and neuromyelitis Optica spectrum disorder. Front Neurosci 17:1214652","journal-title":"Front Neurosci"},{"key":"3073_CR23","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1038\/s41598-019-45433-3","volume":"9","author":"F Ciccocioppo","year":"2019","unstructured":"Ciccocioppo F, Lanuti P, Pierdomenico L, Simeone P, Bologna G, Ercolino E, Buttari F, Fantozzi R, Thomas A, Onofrj M, Centonze D, Miscia S, Marchisio M (2019) The characterization of regulatory T-cell profiles in alzheimer\u2019s disease and multiple sclerosis. Sci Rep 9:8788","journal-title":"Sci Rep"},{"key":"3073_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468","journal-title":"Annu Rev Immunol"},{"key":"3073_CR25","doi-asserted-by":"publisher","first-page":"254248232513161","DOI":"10.1177\/25424823251316134","volume":"9","author":"R Cottrill","year":"2025","unstructured":"Cottrill R, Ekanayake A, Grove C, Peiris S, Corbett N, Ahmed B, Jens W, Brearly T, Kanekar S, Eslinger P, Yang Q, Karunanayaka P (2025) Alzheimer\u2019s disease (AD) in multiple sclerosis (MS): A systematic review of published cases, mechanistic links between AD and MS, and possible clinical evaluation of AD in MS. J Alzheimers Dis Rep 9:25424823251316134","journal-title":"J Alzheimers Dis Rep"},{"key":"3073_CR26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1212\/01.wnl.0000326262.67613.fe","volume":"71","author":"LA Cushman","year":"2008","unstructured":"Cushman LA, Stein K, Duffy CJ (2008) Detecting navigational deficits in cognitive aging and alzheimer disease using virtual reality. Neurology 71:888\u2013895","journal-title":"Neurology"},{"key":"3073_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.21240","volume":"63","author":"A Dal Bianco","year":"2008","unstructured":"Dal Bianco A, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H (2008) Multiple sclerosis and alzheimer\u2019s disease. Ann Neurol 63:174\u2013183","journal-title":"Ann Neurol"},{"key":"3073_CR28","doi-asserted-by":"publisher","first-page":"110990","DOI":"10.1016\/j.jocn.2024.110990","volume":"132","author":"S Daneshvar","year":"2025","unstructured":"Daneshvar S, Moradi F, Rahmani M, Golshaniniya P, Frounchi N, Seifimansour S, Talebi M, Sanaie S, Naseri A (2025) Association of serum levels of inflammation and oxidative stress markers with cognitive outcomes in multiple sclerosis; a systematic review. J Clin Neurosci 132:110990","journal-title":"J Clin Neurosci"},{"key":"3073_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0165-5728(02)00464-2","volume":"136","author":"AI Danilov","year":"2003","unstructured":"Danilov AI, Andersson M, Bavand N, Wiklund NP, Olsson T, Brundin L (2003) Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol 136:112\u2013118","journal-title":"J Neuroimmunol"},{"key":"3073_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","volume":"15","author":"UC Dash","year":"2025","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, Panda SK, Kerry RG, Duttaroy AK, Jena AB (2025) Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications. Acta Pharm Sin B 15:15\u201334","journal-title":"Acta Pharm Sin B"},{"key":"3073_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/jamaneurol.2020.4920","volume":"78","author":"E De Meo","year":"2021","unstructured":"De Meo E, Portaccio E, Giorgio A, Ruano L, Goretti B, Niccolai C, Patti F, Chisari CG, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Stampatori C, Simone M, Viterbo RG, Bonacchi R, Rocca MA, De Stefano N, Filippi M, Amato MP (2021) Identifying the distinct cognitive phenotypes in multiple sclerosis. JAMA Neurol 78:414\u2013425","journal-title":"JAMA Neurol"},{"key":"3073_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T, Overhoff K, Steixner-Kumar AA, Subramanian S, Arinrad S, Ruhwedel T, M\u00f6bius W, G\u00f6bbels S, Saher G, Werner HB, Damkou A, Zampar S, Wirths O, Thalmann M, Simons M, Saito T, Saido T, Krueger-Burg D, Kawaguchi R, Willem M, Haass C, Geschwind D, Ehrenreich H, Stassart R, Nave KA (2023) Myelin dysfunction drives amyloid-beta deposition in models of alzheimer\u2019s disease. Nature 618:349\u2013357","journal-title":"Nature"},{"key":"3073_CR33","doi-asserted-by":"publisher","first-page":"1579511","DOI":"10.3389\/fnins.2025.1579511","volume":"19","author":"J Doroszkiewicz","year":"2025","unstructured":"Doroszkiewicz J, Winkel I, Mroczko B (2025) Comparative analysis of neuroinflammatory pathways in alzheimer\u2019s disease, parkinson\u2019s disease, and multiple sclerosis: insights into similarities and distinctions. Front Neurosci 19:1579511","journal-title":"Front Neurosci"},{"key":"3073_CR34","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","volume":"81","author":"B Dubois","year":"2024","unstructured":"Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D, Kivipelto M, Jessen F, Hanseeuw B, Boada M, Barkhof F, Nordberg A, Froelich L, Waldemar G, Frederiksen KS, Padovani A, Planche V, Rowe C, Bejanin A, Ibanez A, Cappa S, Caramelli P, Nitrini R, Allegri R, Slachevsky A, de Souza LC, Bozoki A, Widera E, Blennow K, Ritchie C, Agronin M, Lopera F, Delano-Wood L, Bombois S, Levy R, Thambisetty M, Georges J, Jones DT, Lavretsky H, Schott J, Gatchel J, Swantek S, Newhouse P, Feldman HH, Frisoni GB (2024) Alzheimer disease as a clinical-biological construct - an international working group recommendation. JAMA Neurol 81:1304\u20131311","journal-title":"JAMA Neurol"},{"key":"3073_CR35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.20736","volume":"59","author":"R Dutta","year":"2006","unstructured":"Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478\u2013489","journal-title":"Ann Neurol"},{"key":"3073_CR36","doi-asserted-by":"crossref","unstructured":"Engel S, Graetz C, Salmen A, Muthuraman M, Toenges G, Ambrosius B, Bayas A, Berthele A, Heesen C, Klotz L, K\u00fcmpfel T, Linker RA, Meuth SG, Paul F, Stangel M, Tackenberg B, Then Bergh F, Tumani H, Weber F, Wildemann B, Zettl UK, Antony G, Bittner S, Groppa S, Hemmer B, Wiendl H, Gold R, Zipp F, Lill CM, Luessi F (2020) Is APOE \u03b54 associated with cognitive performance in early MS? Neurol Neuroimmunol Neuroinflamm 7:e728","DOI":"10.1212\/NXI.0000000000000728"},{"key":"3073_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12967-023-04516-6","volume":"21","author":"LY Fan","year":"2023","unstructured":"Fan LY, Yang J, Liu RY, Kong Y, Guo GY, Xu YM (2023) Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of alzheimer\u2019s disease, parkinson\u2019s disease, and multiple sclerosis. J Transl Med 21:649","journal-title":"J Transl Med"},{"key":"3073_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2005.08.018","volume":"245","author":"F Fazekas","year":"2006","unstructured":"Fazekas F, Enzinger C, Ropele S, Schmidt H, Schmidt R, Strasser-Fuchs S (2006) The impact of our genes: consequences of the Apolipoprotein E polymorphism in alzheimer disease and multiple sclerosis. J Neurol Sci 245:35\u201339","journal-title":"J Neurol Sci"},{"key":"3073_CR39","doi-asserted-by":"publisher","first-page":"106174","DOI":"10.1016\/j.nbd.2023.106174","volume":"183","author":"V Fominykh","year":"2023","unstructured":"Fominykh V, Shadrin AA, Jaholkowski PP, Bahrami S, Athanasiu L, Wightman DP, Uffelmann E, Posthuma D, Selb\u00e6k G, Dale AM, Djurovic S, Frei O, Andreassen OA (2023) Shared genetic loci between alzheimer\u2019s disease and multiple sclerosis: crossroads between neurodegeneration and immune system. Neurobiol Dis 183:106174","journal-title":"Neurobiol Dis"},{"key":"3073_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp.57.3.353","volume":"57","author":"B Fontaine","year":"1994","unstructured":"Fontaine B, Seilhean D, Tourbah A, Daumas-Duport C, Duyckaerts C, Benoit N, Devaux B, Hauw JJ, Rancurel G, Lyon-Caen O (1994) Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms. J Neurol Neurosurg Psychiatry 57:353\u2013359","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3073_CR41","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175\u20131189","journal-title":"Brain"},{"key":"3073_CR42","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","volume":"406","author":"GB Frisoni","year":"2025","unstructured":"Frisoni GB, Hansson O, Nichols E, Garibotto V, Schindler SE, van der Flier WM, Jessen F, Villain N, Arenaza-Urquijo EM, Crivelli L, Fortea J, Grinberg LT, Ismail Z, Minoshima S, Ossenkoppele R, Zetterberg H, Petersen RC, Dubois B (2025) New landscape of the diagnosis of alzheimer\u2019s disease. Lancet 406:1389\u20131407","journal-title":"Lancet"},{"key":"3073_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/1673-5374.286949","volume":"16","author":"L Gaetani","year":"2021","unstructured":"Gaetani L, Salvadori N, Chipi E, Gentili L, Borrelli A, Parnetti L, Di Filippo M (2021) Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers. Neural Regen Res 16:36\u201342","journal-title":"Neural Regen Res"},{"key":"3073_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3892\/br.2022.1510","volume":"16","author":"JA Guti\u00e9rrez-Vargas","year":"2022","unstructured":"Guti\u00e9rrez-Vargas JA, Castro-\u00c1lvarez JF, Zapata-Berruecos JF, Abdul-Rahim K, Arteaga-Noriega A (2022) Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in alzheimer\u2019s disease, cerebral ischemia and multiple sclerosis (Review). Biomed Rep 16:27","journal-title":"Biomed Rep"},{"key":"3073_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/13524585221134217","volume":"29","author":"H Hegen","year":"2023","unstructured":"Hegen H, Arrambide G, Gnanapavan S, Kaplan B, Khalil M, Saadeh R, Teunissen C, Tumani H, Villar LM, Willrich MAV, Zetterberg H, Deisenhammer F (2023) Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement. Mult Scler 29:182\u2013195","journal-title":"Mult Scler"},{"key":"3073_CR46","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.neuropsychologia.2004.02.001","volume":"42","author":"JD Henry","year":"2004","unstructured":"Henry JD, Crawford JR, Phillips LH (2004) Verbal fluency performance in dementia of the alzheimer\u2019s type: a meta-analysis. Neuropsychologia 42:1212\u20131222","journal-title":"Neuropsychologia"},{"key":"3073_CR47","doi-asserted-by":"publisher","first-page":"8376","DOI":"10.1007\/s12035-019-01676-9","volume":"56","author":"S Herrera-Espejo","year":"2019","unstructured":"Herrera-Espejo S, Santos-Zorrozua B, \u00c1lvarez-Gonz\u00e1lez P, Lopez-Lopez E, Garcia-Orad \u00c1 (2019) A systematic review of MicroRNA expression as biomarker of late-onset alzheimer\u2019s disease. Mol Neurobiol 56:8376\u20138391","journal-title":"Mol Neurobiol"},{"key":"3073_CR48","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1002\/wdev.358","volume":"9","author":"DM Ho","year":"2020","unstructured":"Ho DM, Artavanis-Tsakonas S, Louvi A (2020) The Notch pathway in CNS homeostasis and neurodegeneration. Wiley Interdiscip Rev Dev Biol 9:e358","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"3073_CR49","doi-asserted-by":"publisher","first-page":"26525","DOI":"10.1038\/s41598-025-09262-x","volume":"15","author":"J Hu","year":"2025","unstructured":"Hu J, Zeng H, Lu J, Li T, Liu X, Liu Y, Wen W, Shen W, Chen H, Chen Z (2025) Preclinical development of an immunoassay for the detection of TREM2: a new biomarker for alzheimer\u2019s disease. Sci Rep 15:26525","journal-title":"Sci Rep"},{"key":"3073_CR50","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archneur.1987.00520190040015","volume":"44","author":"SJ Huber","year":"1987","unstructured":"Huber SJ, Paulson GW, Shuttleworth EC, Chakeres D, Clapp LE, Pakalnis A, Weiss K, Rammohan K (1987) Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol 44:732\u2013736","journal-title":"Arch Neurol"},{"key":"3073_CR51","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jamaneurol.2025.2974","volume":"82","author":"PS Insel","year":"2025","unstructured":"Insel PS, Mattsson-Carlgren N, Langford O, Caruso VM, Leuzy A, Young CB, Boxer A, Aisen PS, Sperling RA, Mormino EC, Donohue MC (2025) Concurrent changes in plasma phosphorylated Tau 217, Tau PET, and cognition in preclinical alzheimer disease. JAMA Neurol 82:985\u2013993","journal-title":"JAMA Neurol"},{"key":"3073_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R (2018) NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562","journal-title":"Alzheimers Dement"},{"key":"3073_CR53","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E, Molinuevo JL, Okonkwo OC, Pani L, Rafii MS, Scheltens P, Siemers E, Snyder HM, Sperling R, Teunissen CE, Carrillo MC (2024) Revised criteria for diagnosis and staging of alzheimer\u2019s disease: alzheimer\u2019s association workgroup. Alzheimers Dement 20:5143\u20135169","journal-title":"Alzheimers Dement"},{"key":"3073_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fnagi.2019.00105","volume":"11","author":"D Jakimovski","year":"2019","unstructured":"Jakimovski D, Weinstock-Guttman B, Roy S, Jaworski M 3rd, Hancock L, Nizinski A, Srinivasan P, Fuchs TA, Szigeti K, Zivadinov R, Benedict RHB (2019) Cognitive profiles of aging in multiple sclerosis. Front Aging Neurosci 11:105","journal-title":"Front Aging Neurosci"},{"key":"3073_CR55","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/WNN.0000000000000252","volume":"33","author":"D Jakimovski","year":"2020","unstructured":"Jakimovski D, Szigeti K, Jaworski M 3rd, Ouf A, Weinstock-Guttman B, Zivadinov R, Benedict RHB (2020) Differential diagnosis of cognitive decline in elderly individuals with multiple sclerosis. Cogn Behav Neurol 33:294\u2013300","journal-title":"Cogn Behav Neurol"},{"key":"3073_CR56","doi-asserted-by":"crossref","unstructured":"Javor J, Bucov\u00e1 M, Durmanov\u00e1 V, Rado\u0161insk\u00e1 D, P\u00e1rnick\u00e1 Z, Cierny D, Kurca E, Cop\u00edkov\u00e1-Cudr\u00e1kov\u00e1 D, Gmitterov\u00e1 K, Shawkatov\u00e1 I (2022) Alzheimer\u2019s disease risk variant rs3865444 in the CD33 gene: a possible role in susceptibility to multiple sclerosis. Life (Basel) 12:1094","DOI":"10.3390\/life12071094"},{"key":"3073_CR57","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA, Munk AS, Lundgaard I, Nedergaard M (2015) The glymphatic system: a beginner\u2019s guide. Neurochem Res 40:2583\u20132599","journal-title":"Neurochem Res"},{"key":"3073_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.arr.2017.08.005","volume":"40","author":"S Jevtic","year":"2017","unstructured":"Jevtic S, Sengar AS, Salter MW, McLaurin J (2017) The role of the immune system in alzheimer disease: etiology and treatment. Ageing Res Rev 40:84\u201394","journal-title":"Ageing Res Rev"},{"key":"3073_CR59","doi-asserted-by":"publisher","first-page":"e","DOI":"10.1016\/j.jalz.2013.01.002","volume":"9","author":"KA Johnson","year":"2013","unstructured":"Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH (2013) Appropriate use criteria for amyloid PET: a report of the amyloid imaging task Force, the society of nuclear medicine and molecular imaging, and the alzheimer\u2019s association. Alzheimers Dement 9:E1\u2013E16","journal-title":"Alzheimers Dement"},{"key":"3073_CR60","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.immuni.2024.09.014","volume":"57","author":"S Kaji","year":"2024","unstructured":"Kaji S, Berghoff SA, Spieth L, Schlaphoff L, Sasmita AO, Vitale S, B\u00fcschgens L, Kedia S, Zirngibl M, Nazarenko T, Damkou A, Hosang L, Depp C, Kamp F, Scholz P, Ewers D, Giera M, Ischebeck T, Wurst W, Wefers B, Schifferer M, Willem M, Nave KA, Haass C, Arzberger T, J\u00e4kel S, Wirths O, Saher G, Simons M (2024) Apolipoprotein E aggregation in microglia initiates alzheimer\u2019s disease pathology by seeding \u00ce\u00b2-amyloidosis. Immunity 57:2651\u20132668 e2612","journal-title":"Immunity"},{"key":"3073_CR61","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","volume":"88","author":"I Kawachi","year":"2017","unstructured":"Kawachi I, Lassmann H (2017) Neurodegeneration in multiple sclerosis and neuromyelitis Optica. J Neurol Neurosurg Psychiatry 88:137\u2013145","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3073_CR62","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1007\/s00415-020-09969-z","volume":"267","author":"M Kolanko","year":"2020","unstructured":"Kolanko M, Win Z, Patel N, Malik O, Carswell C, Gontsarova A, Nicholas R, Perry R, Malhotra P (2020) Using amyloid PET imaging to diagnose alzheimer\u2019s disease in patients with multiple sclerosis. J Neurol 267:3268\u20133273","journal-title":"J Neurol"},{"key":"3073_CR63","doi-asserted-by":"crossref","unstructured":"Kr\u00f3l-Grzymala A, Sienkiewicz-Szlapka E, Fiedorowicz E, Rozmus D, Cieslinska A, Grzybowski A (2022) Tear biomarkers in Alzheimer\u2019s and Parkinson\u2019s diseases, and multiple sclerosis: implications for diagnosis (systematic review). Int J Mol Sci 23:10123","DOI":"10.3390\/ijms231710123"},{"key":"3073_CR64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s40478-022-01444-2","volume":"10","author":"MS LaCroix","year":"2022","unstructured":"LaCroix MS, Mirbaha H, Shang P, Zandee S, Foong C, Prat A, White CL 3rd, Stuve O, Diamond MI (2022) Tau seeding in cases of multiple sclerosis. Acta Neuropathol Commun 10:146","journal-title":"Acta Neuropathol Commun"},{"key":"3073_CR66","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00702-011-0607-8","volume":"118","author":"H Lassmann","year":"2011","unstructured":"Lassmann H (2011) Mechanisms of neurodegeneration shared between multiple sclerosis and alzheimer\u2019s disease. J Neural Transm (Vienna) 118:747\u2013752","journal-title":"J Neural Transm (Vienna)"},{"key":"3073_CR65","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"H Lassmann","year":"2007","unstructured":"Lassmann H, Br\u00fcck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210\u2013218","journal-title":"Brain Pathol"},{"key":"3073_CR67","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, St\u00e4hler C, Lang CJ, Meder B, Bartfai T, Meese E, Keller A (2013) A blood based 12-miRNA signature of alzheimer disease patients. Genome Biol 14:R78","journal-title":"Genome Biol"},{"key":"3073_CR68","doi-asserted-by":"publisher","first-page":"120506","DOI":"10.1016\/j.cca.2025.120506","volume":"578","author":"Q Liu","year":"2026","unstructured":"Liu Q, Siadat SD (2026) MicroRNA-155 in neurodegeneration. Clin Chim Acta 578:120506","journal-title":"Clin Chim Acta"},{"key":"3073_CR69","doi-asserted-by":"publisher","first-page":"fcac167","DOI":"10.1093\/braincomms\/fcac167","volume":"4","author":"DP Londo\u00f1o","year":"2022","unstructured":"Londo\u00f1o DP, Arumaithurai K, Constantopoulos E, Basso MR, Reichard RR, Flanagan EP, Keegan BM (2022) Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis. Brain Commun 4:fcac167","journal-title":"Brain Commun"},{"key":"3073_CR70","doi-asserted-by":"publisher","first-page":"e209663","DOI":"10.1212\/WNL.0000000000209663","volume":"103","author":"FC Loonstra","year":"2024","unstructured":"Loonstra FC, \u00c1lvarez Sirvent D, Tesi N, Holstege H, Strijbis EMM, Salazar AN, Hulsman M, Van Der Lee SJ, Uitdehaag B (2024) Association of polygenic risk score with lifetime risk of developing multiple sclerosis in a population-based birth-year cohort. Neurology 103:e209663","journal-title":"Neurology"},{"key":"3073_CR71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T, Knopman DS, Jones DT, Petrucelli L, Cook CN, Graff-Radford NR, Dickson DW, Petersen RC, Jack CR Jr., Murray ME (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58","journal-title":"Acta Neuropathol Commun"},{"key":"3073_CR72","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.msard.2018.10.109","volume":"27","author":"P Luczynski","year":"2019","unstructured":"Luczynski P, Laule C, Hsiung GR, Moore GRW, Tremlett H (2019) Coexistence of multiple sclerosis and alzheimer\u2019s disease: a review. Mult Scler Relat Disord 27:232\u2013238","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR73","doi-asserted-by":"publisher","first-page":"102757","DOI":"10.1016\/j.eclinm.2024.102757","volume":"74","author":"X Ma","year":"2024","unstructured":"Ma X, Liao Z, Tan H, Wang K, Feng C, Xing P, Zhang X, Hua J, Jiang P, Peng S, Lin H, Liang W, Gao X (2024) The association between cytomegalovirus infection and neurodegenerative diseases: a prospective cohort using UK biobank data. EClinicalMedicine 74:102757","journal-title":"EClinicalMedicine"},{"key":"3073_CR74","doi-asserted-by":"publisher","first-page":"103351","DOI":"10.1016\/j.msard.2021.103351","volume":"57","author":"E Mahmoudi","year":"2022","unstructured":"Mahmoudi E, Sadaghiyani S, Lin P, Kamdar N, Norcott A, Peterson MD, Meade MA (2022) Diagnosis of alzheimer\u2019s disease and related dementia among people with multiple sclerosis: large cohort study, USA. Mult Scler Relat Disord 57:103351","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR75","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12883-015-0502-2","volume":"15","author":"JA Mat\u00edas-Guiu","year":"2015","unstructured":"Mat\u00edas-Guiu JA, Cabrera-Mart\u00edn MN, Mat\u00edas-Guiu J, Oreja-Guevara C, Riola-Parada C, Moreno-Ramos T, Arrazola J, Carreras JL (2015) Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study. BMC Neurol 15:243","journal-title":"BMC Neurol"},{"key":"3073_CR76","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41591-022-01925-w","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0 M, Ashton NJ, Shekari M, Salvad\u00f3 G, Ortiz-Romero P, Montoliu-Gaya L, Benedet AL, Karikari TK, Lantero-Rodriguez J, Vanmechelen E, Day TA, Gonz\u00e1lez-Escalante A, S\u00e1nchez-Benavides G, Minguillon C, Fauria K, Molinuevo JL, Dage JL, Zetterberg H, Gispert JD, Su\u00e1rez-Calvet M, Blennow K (2022) Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical alzheimer\u2019s disease. Nat Med 28:1797\u20131801","journal-title":"Nat Med"},{"key":"3073_CR77","doi-asserted-by":"publisher","first-page":"e0266492","DOI":"10.1371\/journal.pone.0266492","volume":"17","author":"O Mirmosayyeb","year":"2022","unstructured":"Mirmosayyeb O, Ebrahimi N, Barzegar M, Afshari-Safavi A, Bagherieh S, Shaygannejad V (2022) Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis. PLoS ONE 17:e0266492","journal-title":"PLoS ONE"},{"key":"3073_CR78","doi-asserted-by":"publisher","first-page":"e70588","DOI":"10.1002\/brb3.70588","volume":"15","author":"O Mirmosayyeb","year":"2025","unstructured":"Mirmosayyeb O, Dehghani Firouzabadi D, Oraee S, Alinejadfard M, Yazdan Panah M, Vaheb S, Ghoshouni H, Shaygannejad V (2025) Dementia in people with multiple sclerosis: a systematic review and meta-analysis. Brain Behav 15:e70588","journal-title":"Brain Behav"},{"key":"3073_CR79","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/1352458512461392","volume":"19","author":"S M\u00fcller","year":"2013","unstructured":"M\u00fcller S, Saur R, Greve B, Melms A, Hautzinger M, Fallgatter AJ, Leyhe T (2013a) Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment. Mult Scler 19:799\u2013805","journal-title":"Mult Scler"},{"key":"3073_CR80","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1352458512450352","volume":"19","author":"S M\u00fcller","year":"2013","unstructured":"M\u00fcller S, Saur R, Greve B, Melms A, Hautzinger M, Fallgatter AJ, Leyhe T (2013b) Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and alzheimer\u2019s disease. Mult Scler 19:225\u2013232","journal-title":"Mult Scler"},{"key":"3073_CR81","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050","volume":"138","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR Jr., Dickson DW (2015) Clinicopathologic and 11\u00a0C-Pittsburgh compound B implications of thal amyloid phase across the alzheimer\u2019s disease spectrum. Brain 138:1370\u20131381","journal-title":"Brain"},{"key":"3073_CR82","doi-asserted-by":"publisher","first-page":"104011","DOI":"10.1016\/j.msard.2022.104011","volume":"65","author":"A Naseri","year":"2022","unstructured":"Naseri A, Baghernezhad K, Seyedi-Sahebari S, Alhoseini SA, Gholipour-Khalili E, Zafarani F, Talebi M (2022) The association of Apolipoprotein E (ApoE) genotype and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis. Mult Scler Relat Disord 65:104011","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR83","doi-asserted-by":"publisher","first-page":"123562","DOI":"10.1016\/j.jns.2025.123562","volume":"475","author":"F Novarella","year":"2025","unstructured":"Novarella F, Nicolella V, Fiorenza M, Falco F, Monteiro I, Corsini G, Ranucci D, Carotenuto A, Petracca M, Lanzillo R, Salvatore E, Castaldo G, Brescia Morra V, Terracciano D, Moccia M (2025) Neurofilament light chain and alzheimer pathology biomarkers in elderly people with multiple sclerosis. J Neurol Sci 475:123562","journal-title":"J Neurol Sci"},{"key":"3073_CR84","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1093\/infdis\/jiae242","volume":"230","author":"A Onisiforou","year":"2024","unstructured":"Onisiforou A, Zanos P (2024) From viral infections to alzheimer\u2019s disease: unveiling the mechanistic links through systems bioinformatics. J Infect Dis 230:S128\u2013S140","journal-title":"J Infect Dis"},{"key":"3073_CR85","first-page":"764","volume":"140","author":"M Ono","year":"2017","unstructured":"Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, Zhang MR, Higuchi M (2017) Distinct binding of PET ligands PBB3 and AV-1451 to Tau fibril strains in neurodegenerative Tauopathies. Brain 140:764\u2013780","journal-title":"Brain"},{"key":"3073_CR86","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","volume":"389","author":"D Ontaneda","year":"2017","unstructured":"Ontaneda D, Thompson AJ, Fox RJ, Cohen JA (2017) Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function. Lancet 389:1357\u20131366","journal-title":"Lancet"},{"key":"3073_CR87","doi-asserted-by":"publisher","first-page":"106281","DOI":"10.1016\/j.msard.2025.106281","volume":"94","author":"XW Pang","year":"2025","unstructured":"Pang XW, Yang S, Zhang LY, Chen L, Zhu LF, Chu YH, Dong MH, Zhou LQ, Xiao J, Wang W, Qin C, Tian DS (2025) Circulating insulin-like growth factor-1 and the risk of multiple sclerosis: a prospective cohort study. Mult Scler Relat Disord 94:106281","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR88","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/ana.27231","volume":"97","author":"J Pansieri","year":"2025","unstructured":"Pansieri J, Pisa M, Yee S, Gutnikova A, Ridgeon E, Hickman R, Spencer JI, Esiri MM, DeLuca GC (2025) Neuropathological evidence of reduced amyloid beta and neurofibrillary tangles in multiple sclerosis cortex. Ann Neurol 97:1067\u20131073","journal-title":"Ann Neurol"},{"key":"3073_CR89","doi-asserted-by":"crossref","unstructured":"Papiri G, Vignini A, Capriotti L, Verdenelli P, Alia S, Di Paolo A, Fiori C, Baldinelli S, Silvestrini M, Luzzi S (2022) Cerebrospinal fluid alpha-calcitonin gene-related peptide: a comparison between Alzheimer\u2019s disease and multiple sclerosis. Biomolecules 12:199","DOI":"10.3390\/biom12020199"},{"key":"3073_CR90","doi-asserted-by":"crossref","unstructured":"Paul A, Comabella M, Gandhi R (2019) Biomarkers in multiple sclerosis. Cold Spring Harb Perspect Med 9:a029058","DOI":"10.1101\/cshperspect.a029058"},{"key":"3073_CR91","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1038\/cti.2016.87","volume":"6","author":"MP Pender","year":"2017","unstructured":"Pender MP, Csurhes PA, Burrows JM, Burrows SR (2017) Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clin Transl Immunol 6:e126","journal-title":"Clin Transl Immunol"},{"key":"3073_CR92","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, Zetterberg H, Stomrud E, Ashton NJ, Blennow K, Hansson O (2021) Plasma GFAP is an early marker of amyloid-beta but not Tau pathology in alzheimer\u2019s disease. Brain 144:3505\u20133516","journal-title":"Brain"},{"key":"3073_CR93","doi-asserted-by":"publisher","first-page":"104096","DOI":"10.1016\/j.msard.2022.104096","volume":"68","author":"J Petitfour","year":"2022","unstructured":"Petitfour J, Ayrignac X, Ginestet N, Prin P, Carra-Dalli\u00e8re C, Hirtz C, Charif M, Lehmann S, Labauge P (2022) CSF beta-amyloid is not a prognostic marker in multiple sclerosis patients. Mult Scler Relat Disord 68:104096","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR94","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/1352458516674566","volume":"23","author":"AM Pietroboni","year":"2017","unstructured":"Pietroboni AM, Schiano di Cola F, Scarioni M, Fenoglio C, Span\u00f2 B, Arighi A, Cioffi SM, Oldoni E, De Riz MA, Basilico P, Calvi A, Fumagalli GG, Triulzi F, Galimberti D, Bozzali M, Scarpini E (2017) CSF beta-amyloid as a putative biomarker of disease progression in multiple sclerosis. Mult Scler 23:1085\u20131091","journal-title":"Mult Scler"},{"key":"3073_CR95","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1177\/1352458518791709","volume":"25","author":"AM Pietroboni","year":"2019","unstructured":"Pietroboni AM, Caprioli M, Carandini T, Scarioni M, Ghezzi L, Arighi A, Cioffi S, Cinnante C, Fenoglio C, Oldoni E, De Riz MA, Basilico P, Fumagalli GG, Colombi A, Giulietti G, Serra L, Triulzi F, Bozzali M, Scarpini E, Galimberti D (2019) CSF beta-amyloid predicts prognosis in patients with multiple sclerosis. Mult Scler 25:1223\u20131231","journal-title":"Mult Scler"},{"key":"3073_CR96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-200868","volume":"78","author":"AM Pietroboni","year":"2020","unstructured":"Pietroboni AM, Colombi A, Carandini T, Scarpini E, Galimberti D, Bozzali M (2020) The role of amyloid-beta in white matter damage: possible common pathogenetic mechanisms in neurodegenerative and demyelinating diseases. J Alzheimers Dis 78:13\u201322","journal-title":"J Alzheimers Dis"},{"key":"3073_CR97","doi-asserted-by":"publisher","first-page":"147464","DOI":"10.1016\/j.brainres.2021.147464","volume":"1764","author":"TM Planas-Font\u00e1nez","year":"2021","unstructured":"Planas-Font\u00e1nez TM, Sainato DM, Sharma I, Dreyfus CF (2021) Roles of astrocytes in response to aging, alzheimer\u2019s disease and multiple sclerosis. Brain Res 1764:147464","journal-title":"Brain Res"},{"key":"3073_CR98","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13550-020-00653-x","volume":"10","author":"MJ Pontecorvo","year":"2020","unstructured":"Pontecorvo MJ, Keene CD, Beach TG, Montine TJ, Arora AK, Devous MD, Sr., Navitsky M, Kennedy I, Joshi AD, Lu M, Serrano GE, Sue LI, Intorcia AJ, Rose SE, Wilson A, Hellstern L, Coleman N, Flitter M, Aldea P, Fleisher AS, Mintun MA, Siderowf A (2020) Comparison of regional flortaucipir PET with quantitative Tau immunohistochemistry in three subjects with alzheimer\u2019s disease pathology: a clinicopathological study. EJNMMI Res 10:65","journal-title":"EJNMMI Res"},{"key":"3073_CR99","doi-asserted-by":"publisher","DOI":"10.1515\/dx-2025-0055","author":"A Puliyakkara","year":"2025","unstructured":"Puliyakkara A, Shirlal A, Pendem S, Priyanka, Kadavigere R, Marike TS (2025) Myelin water imaging as a quantitative diagnostic tool for neurodegenerative diseases: a systematic review. Diagnosis (Berl). https:\/\/doi.org\/10.1515\/dx-2025-0055","journal-title":"Diagnosis (Berl)"},{"key":"3073_CR100","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/17582024.2025.2530350","volume":"15","author":"JK Rajavoor Muniswamy","year":"2025","unstructured":"Rajavoor Muniswamy JK, Reshi A, Roy Chowdhury D, Kumar MP (2025) Multiple sclerosis as a genetic risk factor for alzheimer\u2019s disease: insights from Mendelian randomisation. Neurodegener Dis Manag 15:209\u2013221","journal-title":"Neurodegener Dis Manag"},{"key":"3073_CR101","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1212\/WNL.41.5.685","volume":"41","author":"SM Rao","year":"1991","unstructured":"Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685\u2013691","journal-title":"Neurology"},{"key":"3073_CR102","doi-asserted-by":"publisher","first-page":"639369","DOI":"10.3389\/fimmu.2021.639369","volume":"12","author":"B Rossi","year":"2021","unstructured":"Rossi B, Santos-Lima B, Terrabuio E, Zenaro E, Constantin G (2021) Common peripheral immunity mechanisms in multiple sclerosis and Alzheimer\u2019s disease. Front Immunol 12:639369","journal-title":"Front Immunol"},{"key":"3073_CR103","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1037\/neu0000453","volume":"32","author":"AK Roth","year":"2018","unstructured":"Roth AK, Denney DR, Burns JM, Lynch SG (2018) Cognition in older patients with multiple sclerosis compared to patients with amnestic mild cognitive impairment and healthy older adults. Neuropsychology 32:654\u2013663","journal-title":"Neuropsychology"},{"key":"3073_CR104","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.msard.2018.03.008","volume":"22","author":"S Roy","year":"2018","unstructured":"Roy S, Drake A, Snyder S, Cline B, Khan A, Fuchs T, Zivadinov R, Weinstock-Guttman B, Szigeti K, Benedict RHB (2018) Preliminary investigation of cognitive function in aged multiple sclerosis patients: challenges in detecting comorbid alzheimer\u2019s disease. Mult Scler Relat Disord 22:52\u201356","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR105","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, Senda K, Murayama S, Ishii K, Takao M, Beach TG, Rowe CC, Leverenz JB, Ghetti B, Ironside JW, Catafau AM, Stephens AW, Mueller A, Koglin N, Hoffmann A, Roth K, Reininger C, Schulz-Schaeffer WJ (2015) Florbetaben PET imaging to detect amyloid beta plaques in alzheimer\u2019s disease: phase 3 study. Alzheimers Dement 11:964\u2013974","journal-title":"Alzheimers Dement"},{"key":"3073_CR106","doi-asserted-by":"crossref","unstructured":"Saija C, Curr\u00f2 M, Ientile R, Caccamo D, Bertuccio MP (2025) Impact of alterations in homocysteine, asymmetric dimethylarginine and vitamins-related pathways in some neurodegenerative diseases: a narrative review. Int J Mol Sci 26:3672","DOI":"10.3390\/ijms26083672"},{"key":"3073_CR107","doi-asserted-by":"crossref","unstructured":"Salazar JL, Yang SA, Yamamoto S (2020) Post-developmental roles of Notch signaling in the nervous system. Biomolecules 10:985","DOI":"10.3390\/biom10070985"},{"key":"3073_CR108","doi-asserted-by":"publisher","first-page":"e17123","DOI":"10.15252\/emmm.202217123","volume":"15","author":"G Salvad\u00f3","year":"2023","unstructured":"Salvad\u00f3 G, Ossenkoppele R, Ashton NJ, Beach TG, Serrano GE, Reiman EM, Zetterberg H, Mattsson-Carlgren N, Janelidze S, Blennow K, Hansson O (2023) Specific associations between plasma biomarkers and postmortem amyloid plaque and Tau tangle loads. EMBO Mol Med 15:e17123","journal-title":"EMBO Mol Med"},{"key":"3073_CR109","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3892\/etm.2024.12702","volume":"28","author":"TG Schreiner","year":"2024","unstructured":"Schreiner TG, Romanescu C, Schreiner OD, Nhambasora F (2024) New insights on the link between Epstein-Barr virus infection and cognitive decline in neurodegenerative diseases (Review). Exp Ther Med 28:413","journal-title":"Exp Ther Med"},{"key":"3073_CR110","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0165-5728(02)00037-1","volume":"125","author":"F Sellebjerg","year":"2002","unstructured":"Sellebjerg F, Giovannoni G, Hand A, Madsen HO, Jensen CV, Garred P (2002) Cerebrospinal fluid levels of nitric oxide metabolites predict response to Methylprednisolone treatment in multiple sclerosis and optic neuritis. J Neuroimmunol 125:198\u2013203","journal-title":"J Neuroimmunol"},{"key":"3073_CR111","doi-asserted-by":"publisher","first-page":"e213706","DOI":"10.1212\/WNL.0000000000213706","volume":"104","author":"S Shrestha","year":"2025","unstructured":"Shrestha S, Zhu X, Griswold ME, Palta P, Sullivan KJ, Chen H, Schneider ALC, Moghekar A, Grove ML, Thyagarajan B, Pike JR, Gottesman RF, Windham BG, Mosley TH Jr., Deal JA, Kamath V (2025) Olfaction and plasma biomarkers of alzheimer disease and neurodegeneration in the atherosclerosis risk in communities study. Neurology 104:e213706","journal-title":"Neurology"},{"key":"3073_CR112","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1468-1331.2009.02889.x","volume":"17","author":"C Smestad","year":"2010","unstructured":"Smestad C, Sandvik L, Landr\u00f8 NI, Celius EG (2010) Cognitive impairment after three decades of multiple sclerosis. Eur J Neurol 17:499\u2013505","journal-title":"Eur J Neurol"},{"key":"3073_CR113","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM (2023) Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 21:51\u201364","journal-title":"Nat Rev Microbiol"},{"key":"3073_CR114","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/archneurol.2009.190","volume":"66","author":"NP Staff","year":"2009","unstructured":"Staff NP, Lucchinetti CF, Keegan BM (2009) Multiple sclerosis with predominant, severe cognitive impairment. Arch Neurol 66:1139\u20131143","journal-title":"Arch Neurol"},{"key":"3073_CR115","doi-asserted-by":"publisher","first-page":"566225","DOI":"10.3389\/fimmu.2020.566225","volume":"11","author":"Z Stojic-Vukanic","year":"2020","unstructured":"Stojic-Vukanic Z, Had\u017eibegovic S, Nicole O, Nacka-Aleksic M, Le\u0161tarevic S, Leposavic G (2020) CD8\u2009+\u2009T cell-mediated mechanisms contribute to the progression of neurocognitive impairment in both multiple sclerosis and alzheimer\u2019s disease? Front Immunol 11:566225","journal-title":"Front Immunol"},{"key":"3073_CR116","doi-asserted-by":"publisher","first-page":"102870","DOI":"10.1016\/j.msard.2021.102870","volume":"51","author":"M Sun","year":"2021","unstructured":"Sun M, Liu N, Xie Q, Li X, Sun J, Wang H, Wang M (2021) A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis. Mult Scler Relat Disord 51:102870","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR117","doi-asserted-by":"publisher","first-page":"1162340","DOI":"10.3389\/fimmu.2023.1162340","volume":"14","author":"J Temmerman","year":"2023","unstructured":"Temmerman J, Engelborghs S, Bjerke M, D\u2019Haeseleer M (2023) Cerebrospinal fluid inflammatory biomarkers for disease progression in alzheimer\u2019s disease and multiple sclerosis: a systematic review. Front Immunol 14:1162340","journal-title":"Front Immunol"},{"key":"3073_CR118","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-025-00819-y","volume":"20","author":"DR Thal","year":"2025","unstructured":"Thal DR, Poesen K, Vandenberghe R, De Meyer S (2025) Alzheimer\u2019s disease neuropathology and its Estimation with fluid and imaging biomarkers. Mol Neurodegener 20:33","journal-title":"Mol Neurodegener"},{"key":"3073_CR119","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s43587-024-00731-y","volume":"4","author":"J Therriault","year":"2024","unstructured":"Therriault J, Janelidze S, Benedet AL, Ashton NJ, Arranz Mart\u00ednez J, Gonzalez-Escalante A, Bellaver B, Alcolea D, Vrillon A, Karim H, Mielke MM, Hyung Hong C, Roh HW, Contador J, Puig Pijoan A, Algeciras-Schimnich A, Vemuri P, Graff-Radford J, Lowe VJ, Karikari TK, Jonaitis E, Brum W, Tissot C, Servaes S, Rahmouni N, Macedo AC, Stevenson J, Fernandez-Arias J, Wang YT, Woo MS, Friese MA, Jia WL, Dumurgier J, Hourregue C, Cognat E, Ferreira PL, Vitali P, Johnson S, Pascoal TA, Gauthier S, Lle\u00f3 A, Paquet C, Petersen RC, Salmon D, Mattsson-Carlgren N, Palmqvist S, Stomrud E, Galasko D, Son SJ, Zetterberg H, Fortea J, Su\u00e1rez-Calvet M, Jack CR Jr., Blennow K, Hansson O, Rosa-Neto P (2024) Diagnosis of alzheimer\u2019s disease using plasma biomarkers adjusted to clinical probability. Nat Aging 4:1529\u20131537","journal-title":"Nat Aging"},{"key":"3073_CR120","doi-asserted-by":"publisher","first-page":"8918","DOI":"10.1080\/07391102.2022.2138978","volume":"41","author":"D Tiwari","year":"2023","unstructured":"Tiwari D, Srivastava G, Indari O, Tripathi V, Siddiqi MI, Jha HC (2023) An in-silico insight into the predictive interaction of Apolipoprotein-E with Epstein-Barr virus proteins and their probable role in mediating alzheimer\u2019s disease. J Biomol Struct Dyn 41:8918\u20138926","journal-title":"J Biomol Struct Dyn"},{"key":"3073_CR121","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/1352458515604382","volume":"22","author":"WO Tobin","year":"2016","unstructured":"Tobin WO, Popescu BF, Lowe V, Pirko I, Parisi JE, Kantarci K, Fields JA, Bruns MB, Boeve BF, Lucchinetti CF (2016) Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings. Mult Scler 22:698\u2013704","journal-title":"Mult Scler"},{"key":"3073_CR122","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00002093-199903000-00006","volume":"13","author":"H Tounsi","year":"1999","unstructured":"Tounsi H, Deweer B, Ergis AM, Van der Linden M, Pillon B, Michon A, Dubois B (1999) Sensitivity to semantic cuing: an index of episodic memory dysfunction in early alzheimer disease. Alzheimer Dis Assoc Disord 13:38\u201346","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3073_CR123","doi-asserted-by":"crossref","unstructured":"Uchida Y, Kan H, Sakurai K, Horimoto Y, Hayashi E, Iida A, Okamura N, Oishi K, Matsukawa N (2022) APOE \u03b54 dose associates with increased brain iron and beta-amyloid via blood-brain barrier dysfunction. J Neurol Neurosurg Psychiatry 93:772\u2013778","DOI":"10.1136\/jnnp-2021-328519"},{"key":"3073_CR124","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/eji.202048739","volume":"51","author":"J van Langelaar","year":"2021","unstructured":"van Langelaar J, Wierenga-Wolf AF, Samijn JPA, Luijks CJM, Siepman TA, van Doorn PA, Bell A, van Zelm MC, Smolders J, van Luijn MM (2021) The association of Epstein-Barr virus infection with CXCR3(+) B-cell development in multiple sclerosis: impact of immunotherapies. Eur J Immunol 51:626\u2013633","journal-title":"Eur J Immunol"},{"key":"3073_CR125","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/brain\/awp337","volume":"133","author":"S Veto","year":"2010","unstructured":"Veto S, Acs P, Bauer J, Lassmann H, Berente Z, Setalo G Jr., Borgulya G, Sumegi B, Komoly S, Gallyas F Jr., Illes Z (2010) Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. Brain 133:822\u2013834","journal-title":"Brain"},{"key":"3073_CR126","doi-asserted-by":"publisher","first-page":"105678","DOI":"10.1016\/j.msard.2024.105678","volume":"87","author":"L Vidorreta-Ballesteros","year":"2024","unstructured":"Vidorreta-Ballesteros L, Matias-Guiu JA, Delgado-\u00c1lvarez A, Delgado-Alonso C, Valles-Salgado M, Cuevas C, Gil-Moreno MJ, Garc\u00eda-Ramos R, Montero-Escribano P, Matias-Guiu J (2024) Cognitive dysfunction characteristics of multiple sclerosis with aging. Mult Scler Relat Disord 87:105678","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR127","doi-asserted-by":"publisher","first-page":"103231","DOI":"10.1016\/j.msard.2021.103231","volume":"56","author":"E Virgilio","year":"2021","unstructured":"Virgilio E, Vecchio D, Crespi I, Serino R, Cantello R, Dianzani U, Comi C (2021) Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis. Mult Scler Relat Disord 56:103231","journal-title":"Mult Scler Relat Disord"},{"key":"3073_CR128","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00415-021-10945-4","volume":"269","author":"E Virgilio","year":"2022","unstructured":"Virgilio E, Vecchio D, Crespi I, Puricelli C, Barbero P, Galli G, Cantello R, Dianzani U, Comi C (2022) Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis. J Neurol 269:3249\u20133257","journal-title":"J Neurol"},{"key":"3073_CR129","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","volume":"25","author":"S Voet","year":"2019","unstructured":"Voet S, Prinz M, van Loo G (2019) Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med 25:112\u2013123","journal-title":"Trends Mol Med"},{"key":"3073_CR130","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbi.2021.12.008","volume":"100","author":"Y Wang","year":"2022","unstructured":"Wang Y, Grydeland H, Roe JM, Pan M, Magnussen F, Amlien IK, Watne LO, Idland AV, Bertram L, Gundersen TE, Pascual-Leone A, Cabello-Toscano M, Tormos JM, Bartres-Faz D, Drevon CA, Fjell AM, Walhovd KW (2022) Associations of Circulating C-reactive proteins, APOE \u03b54, and brain markers for alzheimer\u2019s disease in healthy samples across the lifespan. Brain Behav Immun 100:243\u2013253","journal-title":"Brain Behav Immun"},{"key":"3073_CR131","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/cns.14129","volume":"29","author":"ZT Wang","year":"2023","unstructured":"Wang ZT, Fu Y, Chen SD, Huang YY, Ma YH, Wang YJ, Tan L, Yu JT (2023) Association of rs2062323 in the TREM1 gene with alzheimer\u2019s disease and cerebrospinal fluid-soluble TREM2. CNS Neurosci Ther 29:1657\u20131666","journal-title":"CNS Neurosci Ther"},{"key":"3073_CR132","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41582-024-01046-7","volume":"21","author":"HL Weiner","year":"2025","unstructured":"Weiner HL (2025) Immune mechanisms and shared immune targets in neurodegenerative diseases. Nat Rev Neurol 21:67\u201385","journal-title":"Nat Rev Neurol"},{"key":"3073_CR133","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, Rongve A, B\u00f8rte S, Winsvold BS, Drange OK, Martinsen AE, Skogholt AH, Willer C, Br\u00e5then G, Bosnes I, Nielsen JB, Fritsche LG, Thomas LF, Pedersen LM, Gabrielsen ME, Johnsen MB, Meisingset TW, Zhou W, Proitsi P, Hodges A, Dobson R, Velayudhan L, Heilbron K, Auton A, Sealock JM, Davis LK, Pedersen NL, Reynolds CA, Karlsson IK, Magnusson S, Stefansson H, Thordardottir S, Jonsson PV, Snaedal J, Zettergren A, Skoog I, Kern S, Waern M, Zetterberg H, Blennow K, Stordal E, Hveem K, Zwart JA, Athanasiu L, Selnes P, Saltvedt I, Sando SB, Ulstein I, Djurovic S, Fladby T, Aarsland D, Selb\u00e6k G, Ripke S, Stefansson K, Andreassen OA, Posthuma D (2021) A genome-wide association study with 1,126,563 individuals identifies new risk loci for alzheimer\u2019s disease. Nat Genet 53:1276\u20131282","journal-title":"Nat Genet"},{"key":"3073_CR134","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","volume":"74","author":"A Witoelar","year":"2017","unstructured":"Witoelar A, Jansen IE, Wang Y, Desikan RS, Gibbs JR, Blauwendraat C, Thompson WK, Hernandez DG, Djurovic S, Schork AJ, Bettella F, Ellinghaus D, Franke A, Lie BA, McEvoy LK, Karlsen TH, Lesage S, Morris HR, Brice A, Wood NW, Heutink P, Hardy J, Singleton AB, Dale AM, Gasser T, Andreassen OA, Sharma M (2017) Genome-wide Pleiotropy between Parkinson disease and autoimmune diseases. JAMA Neurol 74:780\u2013792","journal-title":"JAMA Neurol"},{"key":"3073_CR135","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40478-018-0535-z","volume":"6","author":"MC Wren","year":"2018","unstructured":"Wren MC, Lashley T, \u00c5rstad E, Sander K (2018) Large inter- and intra-case variability of first generation Tau PET ligand binding in neurodegenerative dementias. Acta Neuropathol Commun 6:34","journal-title":"Acta Neuropathol Commun"},{"key":"3073_CR136","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1567205019666220202120638","volume":"19","author":"J Wu","year":"2022","unstructured":"Wu J, Zhu S, Zhao C, Xu X (2022) A comprehensive investigation of molecular signatures and pathways linking alzheimer\u2019s disease and epilepsy via bioinformatic approaches. Curr Alzheimer Res 19:146\u2013160","journal-title":"Curr Alzheimer Res"},{"key":"3073_CR137","doi-asserted-by":"publisher","first-page":"e14169","DOI":"10.1371\/journal.pone.0014169","volume":"5","author":"Z Xia","year":"2010","unstructured":"Xia Z, Chibnik LB, Glanz BI, Liguori M, Shulman JM, Tran D, Khoury SJ, Chitnis T, Holyoak T, Weiner HL, Guttmann CR, De Jager PL (2010) A putative alzheimer\u2019s disease risk allele in PCK1 influences brain atrophy in multiple sclerosis. PLoS ONE 5:e14169","journal-title":"PLoS ONE"},{"key":"3073_CR138","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","volume":"53","author":"L Xu","year":"2016","unstructured":"Xu L, He D, Bai Y (2016) Microglia-Mediated inflammation and neurodegenerative disease. Mol Neurobiol 53:6709\u20136715","journal-title":"Mol Neurobiol"},{"key":"3073_CR139","doi-asserted-by":"publisher","first-page":"1233601","DOI":"10.3389\/fnins.2023.1233601","volume":"17","author":"H Xue","year":"2023","unstructured":"Xue H, Zeng L, Liu S (2023) Unraveling the link: exploring the causal relationship between diabetes, multiple sclerosis, migraine, and alzheimer\u2019s disease through Mendelian randomization. Front Neurosci 17:1233601","journal-title":"Front Neurosci"},{"key":"3073_CR140","doi-asserted-by":"publisher","first-page":"e0297091","DOI":"10.1371\/journal.pone.0297091","volume":"19","author":"S Yaghoobpoor","year":"2024","unstructured":"Yaghoobpoor S, Fathi M, Vakili K, Sayehmiri F, Alipour M, Miriran ZS, Ghayyem H, Tutunchian Z, Hajibeygi R, Batool Z, Mirzadeh M, Aghazadeh MH, Hajiesmaeili M (2024) Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis. PLoS ONE 19:e0297091","journal-title":"PLoS ONE"},{"key":"3073_CR141","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1093\/brain\/awaf211","volume":"148","author":"L Yu","year":"2025","unstructured":"Yu L, Du L, Wang T, Barnes LL, Dage JL, Russ KA, Foroud T, Bennett DA, Schneider JA, Boyle PA (2025) Neuropathologic correlates of distinct plasma biomarker profiles in community-living older adults. Brain 148:3340\u20133349","journal-title":"Brain"},{"key":"3073_CR142","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000533397","volume":"86","author":"D Yuan","year":"2023","unstructured":"Yuan D, Huang B, Gu M, Qin BE, Su Z, Dai K, Peng FH, Jiang Y (2023) Exploring shared genetic signatures of alzheimer\u2019s disease and multiple sclerosis: a bioinformatic analysis study. Eur Neurol 86:363\u2013376","journal-title":"Eur Neurol"},{"key":"3073_CR143","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00415-024-12797-0","volume":"272","author":"A Zangh\u00ec","year":"2025","unstructured":"Zangh\u00ec A, Greco A, Giancipoli E, Tumani H, Avolio C, D\u2019Amico E (2025) Unraveling the inflammation-degeneration tangle in early MS: preliminary insights from ferritin, neurogranin, TREM2, and retinal ganglion cell layer. J Neurol 272:109","journal-title":"J Neurol"},{"key":"3073_CR144","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2005.08.025","volume":"245","author":"M Zarei","year":"2006","unstructured":"Zarei M (2006) Clinical characteristics of cortical multiple sclerosis. J Neurol Sci 245:53\u201358","journal-title":"J Neurol Sci"},{"key":"3073_CR145","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-030-60204-8_8","volume":"1299","author":"A Zarrouk","year":"2020","unstructured":"Zarrouk A, Nury T, El Hajj HI, Gondcaille C, Andreoletti P, Moreau T, Cherkaoui-Malki M, Berger J, Hammami M, Lizard G, Vejux A (2020) Potential involvement of peroxisome in multiple sclerosis and alzheimer\u2019s disease: peroxisome and neurodegeneration. Adv Exp Med Biol 1299:91\u2013104","journal-title":"Adv Exp Med Biol"},{"key":"3073_CR149","doi-asserted-by":"crossref","unstructured":"Zeydan B, Kantarci K (2025) Influence of age and sex on presymptomatic phases of neurodegenerative diseases: Focus on multiple sclerosis and Alzheimer\u2019s disease. Rev Neurol (Paris) 181:829\u2013838","DOI":"10.1016\/j.neurol.2025.06.015"},{"key":"3073_CR146","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/1352458517707346","volume":"24","author":"B Zeydan","year":"2018","unstructured":"Zeydan B, Lowe VJ, Schwarz CG, Przybelski SA, Tosakulwong N, Zuk SM, Senjem ML, Gunter JL, Roberts RO, Mielke MM, Benarroch EE, Rodriguez M, Machulda MM, Lesnick TG, Knopman DS, Petersen RC, Jack CR Jr., Kantarci K, Kantarci OH (2018) Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis. Mult Scler 24:739\u2013749","journal-title":"Mult Scler"},{"key":"3073_CR147","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ana.25684","volume":"87","author":"B Zeydan","year":"2020","unstructured":"Zeydan B, Lowe VJ, Reichard RR, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Parisi JE, Machulda MM, Vemuri P, Mielke MM, Knopman DS, Petersen RC, Jack CR Jr., Kantarci OH, Kantarci K (2020a) Imaging biomarkers of alzheimer disease in multiple sclerosis. Ann Neurol 87:556\u2013567","journal-title":"Ann Neurol"},{"key":"3073_CR148","doi-asserted-by":"publisher","unstructured":"Zeydan B, Lowe vJ, Reichard RR, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Parisi JE, Machulda MM, Vemuri P, Mielke MM, Knopman DS, Petersen RC, Jack OH Jr., Kantarci K (2020b) Multiple sclerosis is associated with lower amyloid but normal tau burden on PET. Alzheimers Dement 16 (S5):e039179. https:\/\/doi.org\/10.1002\/alz.039179","DOI":"10.1002\/alz.039179"},{"key":"3073_CR150","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Xiang X, Li Y, Bu G, Chen XF (2025) TREM2 and sTREM2 in alzheimer\u2019s disease: from mechanisms to therapies. Mol Neurodegener 20:43","journal-title":"Mol Neurodegener"},{"key":"3073_CR151","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/glia.21052","volume":"58","author":"I Ziabreva","year":"2010","unstructured":"Ziabreva I, Campbell G, Rist J, Zambonin J, Rorbach J, Wydro MM, Lassmann H, Franklin RJ, Mahad D (2010) Injury and differentiation following Inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes. Glia 58:1827\u20131837","journal-title":"Glia"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03073-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:02:31Z","timestamp":1785603751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03073-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":151,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3073"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03073-0","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares that he has no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}